Clinical trial
Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent…
NCT00438113 · Nova Scotia Health Authority, Other · Completed
Key facts
| NCT number | NCT00438113 |
|---|---|
| Title | Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF |
| Official title | Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF |
| Acronym | SMAC AF |
| Lead sponsor | Nova Scotia Health Authority, Other |
| Collaborators | Nova Scotia Health Research Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | Aggressive Blood Pressure control |
| Enrollment | 184 |
| Start date | Dec 1, 2009 |
| Primary completion | Sep 1, 2016 |
| Completion | Sep 1, 2016 |
| First posted | Feb 21, 2007 |
| Last update posted | Jun 20, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: